SEC 13F Intelligence

Yong Rong (Hk) Asset Management Ltd / SRNE

Yong Rong (Hk) Asset Management Ltd’s Sorrento Therapeutics In Position

Does Yong Rong (Hk) Asset Management Ltd own Sorrento Therapeutics In (SRNE)? Not currently — the last reported position was 792.0K shares worth $1M in Q3 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$1M
Q3 2022
Shares
792.0K
% of Portfolio
+3.99%
Quarters Held
1
position exited

Position History SRNE

Reported value by quarter
Q3 ’22: $1MQ3 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2022792.0K$1M+3.99%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Yong Rong (Hk) Asset Management Ltd’s full portfolio or all institutional holders of SRNE.